Skip to main content

Advertisement

Log in

Cardiac Magnetic Resonance in Chagas Disease—an Update

  • Cardiac Magnetic Resonance (E Nagel and V Puntmann, Section Editors)
  • Published:
Current Cardiovascular Imaging Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

The purpose of this paper is to review the current role of cardiac magnetic resonance (CMR) in Chagas disease.

Recent Findings

CMR is crucial to detect the cardiac involvement in patients with Chagas disease given its ability to assess ventricular function and allow non-invasive tissue characterization.

Summary

Chagas disease is an emerging health problem in non-endemic areas because of growing population movements. Among other imaging modalities, CMR aids in the early detection of cardiac involvement in Chagas disease, allows stage patients in the course of the cardiomyopathy, stratify patients’ prognosis, and subsequently guides management. In addition to its superior ability to assess global and regional biventricular function, CMR allows the detection and quantification of edema and myocardial fibrosis. In addition to conventional tissue characterization sequences, novel quantitative mapping techniques have emerged and are robust parameters in other inflammatory conditions. Despite its promising role to detect and graduate the inflammatory stage of the disease, no specific data in Chagas heart disease is available yet.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. Moreira HT, Volpe GJ, Marin-Neto JA, Ambale-Venkatesh B, Nwabuo CC, Trad HS, et al. Evaluation of right ventricular systolic function in Chagas disease using cardiac magnetic resonance imaging. Circ Cardiovasc Imaging. 2017;10(3).

  2. Volpe GJ, Moreira HT, Trad HS, Wu KC, Braggion-Santos MF, Santos MK, et al. Left ventricular scar and prognosis in chronic Chagas cardiomyopathy. J Am Coll Cardiol. 2018;72(21):2567–76.

    Article  Google Scholar 

  3. Torreão JA, Ianni BM, Mady C, Naia E, Rassi CH, Nomura C, et al. Myocardial tissue characterization in Chagas’ heart disease by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2015;17:97.

  4. Puntmann VO, D’Cruz D, Smith Z, Pastor A, Choong P, Voigt T, et al. Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus. Circ Cardiovasc Imaging. 2013;6(2):295–301.

    Article  Google Scholar 

  5. Winau L, Hinojar Baydes R, Braner A, Drott U, Burkhardt H, Sangle S, et al. High-sensitive troponin is associated with subclinical imaging biosignature of inflammatory cardiovascular involvement in systemic lupus erythematosus. Ann Rheum Dis. 2018;77(11):1590–8.

  6. Rochitte CE, Coelho-Filho OR. Chagas’ cardiomyopathy [Internet]. Oxford University Press; [citado 29 de octubre de 2019]. Disponible en: https://doi.org/10.1093/med/9780198779735.001.0001/med-9780198779735-chapter-28

  7. Nunes MCP, Badano LP, Marin-Neto JA, Edvardsen T, Fernández-Golfín C, Bucciarelli-Ducci C, et al. Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI). Eur Heart J Cardiovasc Imaging. 2018;19(4):459–460n.

    Article  Google Scholar 

  8. Uellendahl M, de Siqueira M, Calado EB, Kalil-Filho R, Sobral D, Ribeiro C, et al. Cardiac magnetic resonance-verified myocardial fibrosis in Chagas disease: clinical correlates and risk stratification. Arq Bras Cardiol. 2016;107(5):460–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation. 2004;109(10):1250–8.

  10. Diaz A, Diaztagle JJ, Olaya A, Mora G, López-Lima I, Ayala C, et al. Cardiovascular magnetic resonance imaging evidence of edema in chronic Chagasic cardiomyopathy. Cardiol Res Pract. 2019;2019:6420364.

    Article  Google Scholar 

  11. Ferreira VM, Piechnik SK, Dall’Armellina E, Karamitsos TD, Francis JM, Ntusi N, et al. T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. JACC Cardiovasc Imaging. 2013;6(10):1048–58.

    Article  Google Scholar 

  12. Hinojar R, Foote L, Sangle S, Marber M, Mayr M, Carr-White G, et al. Native T1 and T2 mapping by CMR in lupus myocarditis: disease recognition and response to treatment. Int J Cardiol. 2016;222:717–26.

    Article  Google Scholar 

  13. Hinojar R, Foote L, Arroyo Ucar E, Jackson T, Jabbour A, Yu C-Y, et al. Native T1 in discrimination of acute and convalescent stages in patients with clinical diagnosis of myocarditis: a proposed diagnostic algorithm using CMR. JACC Cardiovasc Imaging. 2015;8(1):37–46.

    Article  Google Scholar 

  14. Puntmann VO, Isted A, Hinojar R, Foote L, Carr-White G, Nagel E. T1 and T2 mapping in recognition of early cardiac involvement in systemic sarcoidosis. Radiology. 2017;285(1):63–72.

    Article  Google Scholar 

  15. García-Álvarez A. Myocardial delayed enhancement in Chagas heart disease: ready for the clinical arena? J Am Coll Cardiol. 2018;72(21):2588–90.

    Article  Google Scholar 

  16. Gulati A, Jabbour A, Ismail TF, Guha K, Khwaja J, Raza S, et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA. 2013;309(9):896–908.

    Article  CAS  Google Scholar 

  17. Weng Z, Yao J, Chan RH, He J, Yang X, Zhou Y, et al. Prognostic value of LGE-CMR in HCM: a meta-analysis. JACC Cardiovasc Imaging. 2016;9(12):1392–402.

  18. Regueiro A, García-Álvarez A, Sitges M, Ortiz-Pérez JT, De Caralt MT, Pinazo MJ, et al. Myocardial involvement in Chagas disease: insights from cardiac magnetic resonance. Int J Cardiol. 2013;165(1):107–12.

    Article  Google Scholar 

  19. Rassi A, Rassi A, Little WC, Xavier SS, Rassi SG, Rassi AG, et al. Development and validation of a risk score for predicting death in Chagas’ heart disease. N Engl J Med. 2006;355(8):799–808.

    Article  CAS  Google Scholar 

  20. Senra T, Ianni BM, Costa ACP, Mady C, Martinelli-Filho M, Kalil-Filho R, et al. Long-term prognostic value of myocardial fibrosis in patients with Chagas cardiomyopathy. J Am Coll Cardiol. 2018;72(21):2577–87.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rocío Hinojar.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Topical Collection on Cardiac Magnetic Resonance

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pascual Izco, M., Hinojar, R., Zamorano Gómez, J.L. et al. Cardiac Magnetic Resonance in Chagas Disease—an Update. Curr Cardiovasc Imaging Rep 13, 12 (2020). https://doi.org/10.1007/s12410-020-9532-2

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s12410-020-9532-2

Keywords

Navigation